文献速递医学人工智能与信息学临床试验与 GCP流行病学与生物统计

痴呆的数字检测(D3):一项实用性整群随机试验的研究方案,考察患者报告结局与被动临床决策支持系统的应用

Digital detection of dementia (D3): a study protocol for a pragmatic cluster-randomized trial examining the application of patient-reported outcomes and passive clinical decision support systems.
PubMed 文献 · Trials · 2022-10-11

本研究为实用性整群随机临床试验方案,在佛罗里达州南部和印第安纳州的初级保健诊所开展,将诊所随机分配至三组:单独使用基于电子健康记录数据的机器学习被动数字标志物(PDM)、PDM联合患者报告结局快速痴呆评定量表(QDRS)、或两者均不使用,每人群1200例,总计7200例。假设同时使用PDM和QDRS可提高阿尔茨海默病及相关痴呆(ADRD)的诊断发生率及接受诊断检查方案的比例。

要点

  • 在初级保健中比较被动数字标志物与患者报告结局联合或单独使用对ADRD早期检测的效果。
  • 诊所随机分配至三组,每人群1200例,总计7200例,执行检查的医生对分组设盲。
  • 假设PDM联合QDRS可提高ADRD诊断发生率和接受诊断检查方案的比例。

核心结论

  • 本研究旨在检验PDM和QDRS两种可扩展方法在初级保健老年人中早期检测ADRD的准确性和有效性。
  • 研究数据可能促成全国性ADRD早期检测和管理项目,作为减轻当前和未来ADRD负担的有效方法,并提高初级保健中ADRD新记录的年率。

研究设计与样本

  • 实用性整群随机临床试验,诊所被随机分配至三个研究组。
  • 在佛罗里达州南部和印第安纳州的诊所开展,每人群1200例,总计7200例。
  • 三组分别为:单独施测PDM、PDM联合QDRS、两者均不施测。
  • 执行检查方案的医生对患者的研究分组设盲。

主要发现

  • 已开发基于机器学习算法应用于电子健康记录数据的被动数字标志物(PDM),并与患者报告结局快速痴呆评定量表(QDRS)配对,以快速将识别的损害风险分享给患者的医生。
  • 假设同时施测PDM和QDRS时,ADRD诊断发生率和接受ADRD诊断检查方案的比例均增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early detection of Alzheimer's disease and related dementias (ADRD) in a primary care setting is challenging due to time constraints and stigma. The implementation of scalable, sustainable, and patient-driven processes may improve early detection of ADRD; however, there are competing approaches; information may be obtained either directly from a patient (e.g., through a questionnaire) or passively using electronic health record (EHR) data. In this study, we aim to identify the benefit of a combined approach using a pragmatic cluster-randomized clinical trial. METHODS: We have developed a Passive Digital Marker (PDM), based on machine learning algorithms applied to EHR data, and paired it with a patient-reported outcome (the Quick Dementia Rating Scale or QDRS) to rapidly share an identified risk of impairment to a patient's physician. Clinics in both south Florida and Indiana will be randomly assigned to one of three study arms: 1200 patients in each of the two populations will be administered either the PDM, the PDM with the QDRS, or neither, for a total of 7200 patients across all clinics and populations. Both incidence of ADRD diagnosis and acceptance into ADRD diagnostic work-up regimens is hypothesized to increase when patients are administered both the PDM and QDRS. Physicians performing the work-up regimens will be blind to the study arm of the patient. DISCUSSION: This study aims to test the accuracy and effectiveness of the two scalable approaches (PDM and QDRS) for the early detection of ADRD among older adults attending primary care practices. The data obtained in this study may lead to national early detection and management program for ADRD as an efficient and beneficial method of reducing the current and future burden of ADRD, as well as improving the annual rate of newly documented ADRD in primary care practices. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05231954 . Registered February 9, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kleiman MJ, Plewes AD, Owora A, et al. Digital detection of dementia (D3): a study protocol for a pragmatic cluster-randomized trial examining the application of patient-reported outcomes and passive clinical decision support systems. Trials. 2022. PMID: 36221141. doi:10.1186/s13063-022-06809-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。